On Oct 25, major Wall Street analysts update their ratings for $Honeywell (HON.US)$, with price targets ranging from $215 to $244.
J.P. Morgan analyst Stephen Tusa maintains with a hold rating, and adjusts the target price from $235 to $233.
BofA Securities analyst Andrew Obin downgrades to a hold rating, and adjusts the target price from $250 to $230.
Citi analyst Andrew Kaplowitz maintains with a buy rating, and adjusts the target price from $240 to $244.
Barclays analyst Julian Mitchell maintains with a buy rating, and maintains the target price at $229.
Wells Fargo analyst Joe O'Dea maintains with a hold rating, and adjusts the target price from $207 to $215.
Furthermore, according to the comprehensive report, the opinions of $Honeywell (HON.US)$'s main analysts recently are as follows:
Honeywell's Q3 report was somewhat disappointing, particularly considering previous positive signals about Q3 performance and the optimistic outlook for 2025 trends expressed in September.
Subdued demand trends in certain end markets of Honeywell have had an impact on the stock following the Q3 earnings release. Nonetheless, the sustained emphasis on initiatives aimed at growth and the potential for refining its portfolio are anticipated to underpin its long-term sales growth objectives.
The 10% earnings growth target for Honeywell, which is the median of the projected 8-12% through-cycle growth rate, remains challenging to achieve by 2025. Nevertheless, it is anticipated that this will lead to a recalibration of consensus figures among investors.
Honeywell has adjusted its full-year organic growth forecast downward due to the continued weak demand in Industrial Automation, which is expected to extend into the second half of 2024. Eventually, this growth is anticipated to contribute positively to incremental margins, though such benefits are not projected for the current year.
The ongoing weakness in Honeywell's short-cycle businesses is anticipated to persist until year-end, leading to limited visibility and introducing some uncertainty around growth in 2025. Despite the company's strong long-cycle performance and strategic acquisitions contributing to a more positive outlook, the complexity of the situation heading into 2025, coupled with the continued sluggishness in the short-cycle segment, results in less certainty regarding Honeywell's foundational earnings power. Consequently, the risk/reward proposition for the stock is perceived as more neutral at its current valuation.
Here are the latest investment ratings and price targets for $Honeywell (HON.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月25日，多家華爾街大行更新了$霍尼韋爾 (HON.US)$的評級，目標價介於215美元至244美元。
摩根大通分析師Stephen Tusa維持持有評級，並將目標價從235美元下調至233美元。
美銀證券分析師Andrew Obin下調至持有評級，並將目標價從250美元下調至230美元。
花旗分析師Andrew Kaplowitz維持買入評級，並將目標價從240美元上調至244美元。
巴克萊銀行分析師Julian Mitchell維持買入評級，維持目標價229美元。
富國集團分析師Joe O'Dea維持持有評級，並將目標價從207美元上調至215美元。
此外，綜合報道，$霍尼韋爾 (HON.US)$近期主要分析師觀點如下：
霍尼韋爾的第三季度報告有點令人失望，尤其是考慮到之前有關第三季度表現的積極信號以及2025年趨勢的樂觀展望。
霍尼韋爾在某些終端市場需求走弱的影響下，在第三季度業績發佈後股價受到影響。儘管繼續專注於旨在增長的舉措，並且有望進一步完善其組合的潛力，預計這將支撐其長期銷售增長目標。
作爲預計的8-12%週期增長率中值，霍尼韋爾的10%盈利增長目標在2025年難以實現。然而，預計這將導致投資者之間對共識數據的重新校準。
由於工業自動化需求持續疲弱，霍尼韋爾已調整其全年有機增長預測至下行，預計將延續至2024年下半年。最終，這種增長預計將對溢價率產生積極影響，儘管這些利益預計不會出現在當年。
霍尼韋爾短週期業務持續疲軟，預計將持續到年底，這將導致2025年增長可見性有限，並帶來一些不確定性。儘管公司強勁的長週期表現和戰略收購有助於提升更爲積極的前景，但面臨2025年局勢的複雜性以及短週期部分持續低迷的情況，導致對霍尼韋爾基礎盈利能力的確定性較低。因此，根據當前估值，股票的風險/回報比被視爲相對中立。
以下爲今日6位分析師對$霍尼韋爾 (HON.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
